• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

15,540.0000 JPY 50.0000 0.32%

As of 01:51:05 ET on 09/18/2014.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 15,700.0000 High - Low: 15,700.0000 - 15,540.0000 Primary Exchange: Tokyo
Volume: 41 52-Week Range: 13,070.0000 - 15,730.0000 Beta vs TP17PHRM: 0.9447

ETF Chart for 1621

No chart data available.
  • 1621:JP 15,540.0000
  • 1D
  • 1M
  • 1Y
15,490.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2014-09-18) 15,579.6000
Assets (M) (on 2014-09-18) 647.0000
Shares out (M) 0.04
Market Cap (M) 645.52
% Premium -0.25
Average 52-Week % Premium -0.1461
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 6.87%

Performance for 1621

1-Month +3.13% 1-Year +22.83%
3-Month +10.42% 3-Year +21.29%
Year To Date +11.00% 5-Year +10.94%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 08/29/2014
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 29,000 137,750,000 21.460%
Astellas Pharma Inc 88,100 131,973,800 20.560%
Otsuka Holdings Co Ltd 15,400 58,242,800 9.074%
Daiichi Sankyo Co Ltd 24,400 44,847,200 6.987%
Eisai Co Ltd 9,500 41,282,250 6.431%
Ono Pharmaceutical Co Ltd 3,500 32,480,000 5.060%
Shionogi & Co Ltd 12,100 29,645,000 4.618%
Chugai Pharmaceutical Co Ltd 7,700 25,371,500 3.953%
Santen Pharmaceutical Co Ltd 2,800 16,800,000 2.617%
Taisho Pharmaceutical Holdings 1,900 14,991,000 2.335%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil